http://www.acc.org/Feed?clinicalTopicID=d4ccb5f4-249c-45f4-8f48-d8ecbcf86a58 Clinical Topic Feed: Diabetes and Cardiometabolic Disease en /Latest-in-Cardiology/Articles/2026/04/14/14/19/accel-lite-14apr2026 In this interview, Alison L. Bailey, MD, FACC and  Chiadi E. Ndumele, MD, PhD discuss Addressing Cardiovascular-Kidney-Metabolic Syndrome Health. 1776178140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Editors-Corner-Proven-Practical-Patient-First This issue brings together a set of stories united by a central theme familiar to every cardiologist: how high‑quality evidence becomes high‑value care. From prevention in childhood to advanced interventions for complex disease, each story in these pages reflects a different point along the continuum of heart health – yet all focus on turning research into meaningful, practical action. 1775046000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1775045400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Number-Check-New-Clinical-Guideline-Dyslipidemia The new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive "one-stop shop" for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia and elevated lipoprotein(a). 1775045280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-830am-essence-acc-2026 In patients with moderate hypertriglyceridemia, significant reductions in triglyceride and remnant cholesterol levels with olezarsen, on top of standard-of-care lipid-lowering therapy, did not translate into a significant change from baseline in noncalcified coronary plaque volume (NCPV), according to results from Essence-CTA, a substudy of the Essence-TIMI 73b trial, presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774877580000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-1045am-cadence-acc-2026 Sotatercept, an activin signaling inhibitor, was associated with significant improvements in blood pressure and vascular health in patients with heart failure with preserved ejection fraction (HFpEF) and severe combined post and precapillary pulmonary hypertension (CpcPH), according to results of the CADENCE study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774800360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026 Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session... 1774791180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/24/18/15/Consumer-Science-acc-2026 From screen time and alcohol choices to vaccination and blood pressure trends, new research being presented at ACC.26 highlights how everyday behaviors and preventive care can significantly shape cardiovascular risk – especially for younger adults and women. 1774453320000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025 In this week’s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. 1773842400000 Articles and Stories